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Cyclic di-guanosinemonophosphate (c-di-GMP)
is a ubiquitous bacterial second messenger
involved in the regulation of cell surface-asso-
ciated traits and persistence. We have deter-
mined the crystal structure of PleD from Caulo-
bacter crescentus, a response regulator with
a diguanylate cyclase (DGC) domain, in its acti-
vated form. The BeF3
 modification of its re-
ceiver domain causes rearrangement with re-
spect to an adaptor domain, which, in turn,
promotes dimer formation, allowing for the effi-
cient encounter of two symmetric catalytic do-
mains. The substrate analog GTPaS and two
putative cations are bound to the active sites
in a manner similar to adenylate cyclases, sug-
gestingananalogous two-metal catalyticmech-
anism. An allosteric c-di-GMP-binding mode
that crosslinks DGC and an adaptor domain
had been identified before. Here, a second
mode is observed that crosslinks the DGC do-
mains within a PleD dimer. Both modes cause
noncompetitive product inhibition by domain
immobilization.
INTRODUCTION
The central role of bis-(30/ 50)-cyclic di-guanosinemono-
phosphate (c-di-GMP) as a signaling molecule has been
realized only upon the recent recognition of the omnipres-
ence of genes coding for diguanylate cyclase domains
(DGC or GGDEF domains) in bacterial genomes. C-di-
GMP regulates cell surface-associated traits and commu-
nity behavior such as biofilm formation in most eubacteria
(Jenal and Malone, 2006), and its relevance to the viru-
lence of pathogenic bacteria has been demonstrated
(Tischler and Camilli, 2004). In particular, the dinucleotide
has been proposed to orchestrate the switch between
acute and persistent phases of infection (Malone et al.,Structure 15, 912007). C-di-GMP is synthesized out of two molecules of
GTP and is degraded into the linear dinucleotide pGpG
by the opposing activities of DGCs and c-di-GMP-specific
phosphodiesterases. Both enzymes occur in combina-
tions with various other, mostly sensory or regulatory, do-
mains. It is believed that in this way environmental or inter-
nal stimuli can control the production of c-di-GMP, which,
in turn, will affect downstream targets (Jenal and Malone,
2006). One of these c-di-GMP effector domains (PilZ) has
recently been identified (Amikam and Galperin, 2006;
Christen et al., 2007).
About 10% of the known DGCs are response regulators
(RRs) as part of two-component systems (Jenal and
Malone, 2006). RRs are activated by cognate histidine
kinases that phosphorylate a conserved aspartate of the
receiver domain (Rec) (Stock et al., 2000). Various Rec do-
mains have been studied in great detail, and the structural
changes upon activation have been described (for a re-
view, see Robinson et al., 2000).
Due to the instability of the aspartyl phosphoanhydride,
these studies have been performed with phosphoryl ana-
logs. Notably, modification of CheY by beryllium fluoride
(BeF3
) (Lee et al., 2001) resulted in structural changes
fully equivalent to those obtained by phosphorylation
(Birck et al., 1999; Lewis et al., 1999). Upon activation,
a Thr/Ser side chain is pulled toward the modified aspar-
tate, and a Phe/Tyr side chain follows to fill the gap and
changes from a semiexposed to a buried position. Con-
comitantly, mainly the b4-a4 loop of the Rec domain is
changing its conformation. Much less is known about
how these conformational changes elicited in the Rec do-
main are signaled downstream either to target proteins or
to the output domain of full-length RRs. The structures of
full-length CheB (Djordjevic et al., 1998), NarL (Maris et al.,
2002), PrrA (Nowak et al., 2006), and members of the
OmpR/PhoB subfamily (DrrB, DrrD) (Robinson et al., 2003)
have been determined, but only in the nonactivated state.
Distinct mechanisms of activation have been proposed,
such as relief of active site obstruction (e.g., CheB) (Djord-
jevic et al., 1998) (PrrA) (Nowak et al., 2006), dimer or olig-
omer formation (e.g., PhoB) (Bachhawat et al., 2005), or
both (NarL) (Maris et al., 2002).5–927, August 2007 ª2007 Elsevier Ltd All rights reserved 915
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Structure of Activated PleDPleD from Caulobacter crescentus is an unorthodox
RR consisting of a Rec domain (D1) with the phosphorylat-
able aspartate, a Rec-like adaptor domain (D2), and the
enzymatic DGC domain, also called the GGDEF domain
according to a conserved sequence motif. The protein is
intimately involved in the transition of the Caulobacter
cells from the motile to the sessile form (Aldridge et al.,
2003). To gain insight into the molecular mechanisms of
catalysis and regulation exerted by DGCs, we have previ-
ously determined the crystal structure of PleD (Chan et al.,
2004) (Figures 2A and 2C). The fold of DGC (PFAM00990;
http://www.sanger.ac.uk/Software/Pfam/) closely resem-
bles that of class III nucleotidyl cyclases, which include
bacterial and eukaryotic adenylyl cyclases (ACs) (Chan
et al., 2004). A recent review with a detailed comparison
of DGC and AC has been published recently (Sinha and
Sprang, 2006).
Enzymatic studies showed that pseudo phosphoryla-
tion of PleD by BeF3
 results in a 35-fold increase of spe-
cific activity (R.P. et al., unpublished data). The nonacti-
vated structure of PleD (Chan et al., 2004) suggests that
this activation may occur via dimerization of the D1/D2
stem domains, which brings two DGC domains into prox-
imity as a prerequisite for the condensation reaction to
occur (‘‘activation by dimerization’’). At the same time, the
structure showed that the c-di-GMP product crosslinks
the DGC with the adaptor domain, suggesting, together
with biochemical data, that the product allosterically in-
hibits the enzyme by hampering the productive encounter
of the twoDGCdomains of the dimer (‘‘inhibition by immo-
bilization’’). Later, the central role in feedback inhibition of
the allosteric-binding site on the DGCdomain (with a char-
acteristic RxxD sequence motif) was demonstrated by
mutagenesis, genetic screens, and sequence compari-
son, and an alternative allosteric model for the inhibition
mechanism was proposed (Christen et al., 2006).
Here, we present the crystal structure of PleD after
modification of the active aspartate with the phosphoryl
analog BeF3
 and compare it with the nonactivated struc-
ture (Chan et al., 2004). Themodification induces a change
in the relative arrangement of the two Rec domains within
the monomer, resulting in the stabilization of the dimer
that is the catalytically competent form (R.P. et al., unpub-
lished data). Details about the binding mode of the sub-
strate analog GTPaS/Mg2+ are elucidated, and possible
catalytic mechanisms are discussed. Unexpectedly, a
new, to our knowledge, and possibly general mode of
noncompetitive product inhibition for DGCs in which
c-di-GMP immobilizes the two DGC domains of the PleD
dimer in a nonproductive arrangement is revealed.
RESULTS
Dimerization in Solution
Size-exclusion chromatography gave evidence that non-
activated PleD partly dimerizes in a concentration-depen-
dent manner at high protein concentrations (Figure 1A).
Most relevant, dimerization was enhanced by the addition
of BeF3
 and divalent cations (Mg2+ or Mn2+) (Figure 1B),916 Structure 15, 915–927, August 2007 ª2007 Elsevier Ltd All rand the manganese cation was shown to be more effi-
cient. In parallel, BeF3
-induced dimerization has also
been shown via chemical crosslinking, and it was shown
that the dimeric fraction entirely contains the catalytic
activity (R.P. et al., unpublished data).
To thermodynamically quantify the dimerization affinity,
isothermal titration calorimetry (ITC) was performed. Fig-
ure 1C shows the heat peaks measured after injections
of predominantly dimerized PleD into matching buffer; in
the beginning of the titration, the dilution of the titrant is
largest and causes the dissociation of the dimers. Since
dimerization is exothermic in this case, heat is consumed
for dissociation after each injection. With increasing con-
centration in the cell, more and more dimers persist, and
the heat of dissociation decreases gradually. Figure 1D
illustrates two pairs of such data sets obtained by normal-
ization and baseline (Qdil) correction of ITC curves with
activated and nonactivated protein, respectively, on a log-
arithmic scale. Qdil ranged from 1 kcal/mol for the non-
activated PleD mutant to 6 and 3 kcal/mol for the acti-
vated protein, and they include dilution effects and slight
pH or temperature mismatches of titrant and cell content.
At first glance, it is seen that the activated protein dimer-
izes at a much lower concentration. Upon activation with
BeF3
, the fitted dissociation constant, KD, of dimerization
decreased from about 100 mM to < 10 mM. Hereby, the lat-
ter value represents an upper limit, because, for this kind
of experiment, the instrument was close to the detection
limit. The enthalpy of dimerization is 10 kcal/mol for the
nonactivated protein and is apparently somewhat less
exothermic for the activated protein, suggesting that acti-
vation eliminates an entropic hindrance of dimerization.
Structural Changes Induced by Activation
To obtain the structure of activated PleD, crystallization
was attempted with BeF3
-modified protein. Crystals
were obtained upon addition of c-di-GMP, which had
been shown earlier to rigidify the multidomain protein by
crosslinking an allosteric site of the DGC domain with
a neighboring domain (Chan et al., 2004) and the substrate
analog GTPaS/Mg2+ (Table 1). The pseudo phosphoryla-
tion at Asp53 in domain D1 resulted in a train of structural
changes (Figures 2 and 3), ultimately leading to a dramatic
tightening of the dimer interface of the (D1/D2)2 stem com-
pared to the nonactivated structure (Figure 2). Further-
more, but probably not as a consequence of activation,
the arrangement of the DGC domains is drastically differ-
ent from the nonactivated structure.
Asp53 of Rec domain D1 appears fully modified (Figures
3A and 3B) and closely resembles phospho-aspartate
(Lewis et al., 1999), with a Be-O distance of 1.58 A˚ (re-
strained in refinement to 1.55 A˚) and a Cg-Od-Be-F1 dihe-
dral cis conformation. The moiety forms four H bonds with
the binding pocket and contributes to the coordination
of the adjacent Mg2+ ion. The modification results in a re-
structuring of the b4-a4 loop, with Thr83 moving by more
than 3 A˚ relative to the position in the nonactivated state to
form an H bond with the BeF3
 moiety (Figures 3A and
3B). The vacated space, in turn, is claimed by Phe102,ights reserved
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Structure of Activated PleDFigure 1. Size-Exclusion Chromatography Elution Profiles and Isothermal Titration Calorimetry of Purified PleD Mutant R313A
(A–D) This mutant with unmodified dimerization domains had been chosen for technical reasons (availability of material). (A) Elution profiles of
nonactivated PleD at a protein concentration of 33 mM (gray) and 66 mM (black). (B) Elution profiles of BeF3
-modified PleD (66 mM) in presence of
10 mM MgCl2 (gray) and 1 mM MnCl2 (black). Note that c-di-GMP is released and separated from the protein during the runs. (C) The primary ITC
data for a dilution experiment (initial PleD concentration = 0.86 mM) with nonactivated PleD. (D) The integrated two ITC data sets for the activated
(solid symbols) and nonactivated (open symbols) PleD mutant, after subtraction of the baseline heats, Qdil, obtained by model-based extrapolation
of the curves to high concentrations. The curves illustrate the best fits with shared KD values of 100 mM (nonactivated) and 10 mM (activated). Due to
the noisy data, the latter value represents an upper limit.which changes its side chain conformation from gauche+
to trans to become buried; part of the b5 main chain (res-
idues 102–104) moves up to 2 A˚.
Domain D1 interacts closely and in a pseudo two-fold
symmetric manner with the adaptor domain D2 across
the a4-b5-a5 faces of both domains. Activation results
in a domain rotation/shift of 14/6 A˚ of D2 relative to D1
and a massive repacking of the domain interface (Fig-
ure 3A). In Figures 3C and 3D, the D1/D2 interface is dis-
played in its two states. While most of the contacting D1
residues stay in touch with the D2 domain, Arg91, Val110,
and Ile251 contribute to the interface only in the nonacti-
vated state, and residues Arg88, Ile92, Leu95, Val241,
Gln259, and Ala263 contribute only in the activated state.
Amazingly, the three interdomain salt bridges (Asp108-
Arg237, Arg115-Asp250, Asp101-Arg264) are not disrup-
ted during the transition, although the partners move up to
7 A˚ with respect to each other. However, upon activation,
Asp257 swaps its ion-pair partner Arg91 for Arg88. UponStructure 15, 915activation, the hydrophobic contact patch aroundMet111,
Ala114, Met240, and Leu244 becomes repacked, and an
additional apolar contact is formed that involves Ile92,
Leu95, and Ala263 (Figures 3C and 3D).
On the quaternary level, in both crystal structures, the
Rec and the adaptor domains form a dyad symmetric
(D1/D2)2 ‘‘stem’’ with the equivalent domains of a second
monomer (Figure 2). Since both domains contribute to the
interchain interface, it is obvious that the relative reposi-
tioning of the domains within each chain also has conse-
quences on the quaternary structure. The weak dimer in-
terface observed in the nonactivated structure (Chan
et al., 2004) is greatly tightened upon activation (Figures
2C and 2D), and the buried accessible surface areas per
monomer (DASA) increased from 900 A˚2 to 1436 A˚2.
In both states, the interchain contacts between D1 and
D2 are formed in an isologous, i.e., two-fold symmetric
manner. In the nonactivated structure, there is only a small
contact patch around Tyr26 resulting in a discontinuous–927, August 2007 ª2007 Elsevier Ltd All rights reserved 917
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Structure of Activated PleDinterface (Figure 4A). While this contact is maintained in
the activated structure, a multitude of additional interac-
tions are formed involving the a1, b2, b3, a5 face of D1
and the a3, a3-b3, a5 face of D2 (Figure 4B). Three salt
bridges are formed between the subunits, and there is a
sulfate ion on the two-fold symmetry axis at the center
of a basic cluster formed by Arg117 and Arg121 with their
symmetry mates (Figure 4B). In addition, there are a few
polar interactions and a small hydrophobic cluster formed
by Leu124 and Val125 and their symmetry mates.
Upon activation, the a5 helices of the stem domains be-
come extended by 4–5 residues at the C terminus. It is
these helices that experience the largest change in relative
interchain distance, moving from a closest distance of
about 10 A˚ to direct van der Waals contact (Figures 4A
and 4B). Together with their symmetry mates, the C-termi-
nal thirdsof the foura5helices formaparallelahelix bundle
in the dimer (Figure 2B).
Active Site
To gain further insight into the catalytic action of DGCs,
the substrate analog GTPaS and Mg2+ had been added
to the crystallization set-ups. In the activated structure,
both active sites of the DGC domains, which face away
Table 1. Data Collection and Refinement Statistics of
Activated PleD in Complex with c-di-GMP and GTPaS
Data Collection
Space group P21212
Cell dimensions
a, b, c (A˚) 128.9, 132.6, 88.4
Resolution (A˚) 30–2.71 (2.85–2.71)
Rmerge (%) 9.8 (43.6)
I/s(I) 10.2 (1.9)
Completeness (%) 95.0 (78.0)
Redundancy 2.9 (2.4)
Refinement
Number of reflections 39,043
Rwork/Rfree 21.7/25.4
Number of atoms
Protein 7,012
Ligands 272
Water 14
B factors (A˚2)
Protein 41.0
Ligands 43.7
Water 29.2
Rmsds
Bond lengths (A˚) 0.011
Bond angles () 1.5
Data in parentheses belong to the outer resolution shell.918 Structure 15, 915–927, August 2007 ª2007 Elsevier Ltd Allfrom each other (see below), are occupied by the ligands.
Figure 5 shows that the b- and g-phosphates are tightly
bound and form two H bonds to main chain amides of
the short P loop between strand b1 and helix a1 and ionic
interactions to Lys442, Arg446, and a putative Mg2+ ion
(named metal B in analogy to the situation in adenylate
cyclases [Tesmer et al., 1999]). The cation is additionally
coordinated bymain chain carbonyl 328of theP loop, both
carboxylate oxygens of Asp327, and Glu370, OE1. In one
subunit of the dimer (subunit A), a second putative Mg2+
ion (metal A) is bound from another side to the same two
side chains, interacting with atoms Asp327, OD2 and
Glu370, OE2, respectively. Consistent with the structure,
mutation of Asp327 to Ala resulted in a complete loss of
enzymatic activity, as has been seen previously for mutant
E370Q (Christen et al., 2006). The elongated density of the
omit map (Figure 5) and the elevated B factor of the ion (52
A˚2) possibly indicate alternative positions for this ion. Nei-
ther the a-thiophosphate nor the ribose moiety are bound
to the protein by specific interactions, resulting in compar-
atively high B values (60 A˚2). The guanine moiety, in con-
trast, is well adopted, forming H bonds with Asn335 and
Asp344 of the guanine-binding pocket, also already iden-
tified in the nonactivated protein-product complex (Chan
et al., 2004).
Allosteric Product Binding
Compared to the previously determined nonactivated
structure of PleD, the DGC domains adopt a drastically
different position with respect to the stem domains. While,
in the previous structure, the weak D2/DGC interface is
strengthened by a bound c-di-GMP dimer that effectively
crosslinks the domains (Figure 2A), in the present struc-
ture, this interface is completely disrupted and the DGC
domains are swung out to form a two-fold symmetric c-di-
GMP-crosslinked dimer (Figure 6). The difference in the
relative orientation of the DGC domain with respect to the
stem is probably not a direct consequence of Rec modifi-
cation, since, assuming a flexible D2-DGC linker, a change
of the crosslinking mode appears to be structurally feasi-
ble in either state. Thus, both domain organizations would
occur in thermodynamic equilibrium in solution.
C-di-GMP forms dimers with the four guanyl bases
stacked and intercalated as in small-molecule crystals
(Egli et al., 1990; Liaw et al., 1990). Figure 6B shows that
this form is found bound to the allosteric site. Two guanyl
bases interact with DGC residues Arg359, Asp362, and
Arg390 (primary I site, Ip), whereas the neighboring third
base is bonded to Arg313 of the adjacent DGC domain
(secondary I site, IS,DGC). Due to symmetry, there are two
isologous crosslinks within the DGC dimer (Figure 6). The
dimer interface (with a DASA of 517 A˚2 that increases to
1044 A˚2 upon ligand binding) is exclusively hydrophobic
and involves Ala360, Ile361, Pro377, and the hydrophobic
part of the Ser309 side chain. Noteworthy, in the nonacti-
vated structure, a c-di-GMP dimer is bound to Ip in exactly
the same way, but it crosslinks with the third base and a
phosphate moiety to Arg148 and Arg178 of the D2 domain
(IS,D2).rights reserved
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Structure of Activated PleDFigure 2. Ribbon Diagrams of the Dimeric Crystal Structures of Nonactivated PleD and BeF3
-Activated PleD
(A–D) In (A) and (B) the view is perpendicular to the two-fold axis of the stem. In (C) and (D), the view is rotated by 90 around a horizontal axis with
respect to the top panels, showing the bottom view of the (D1/D2)2 stem with the DGC domains in the rear clipped off for clarity. The domains are
colored in red (Rec domain D1), yellow (adaptor domain D2), and green (enzymatic domain DGC, with the GGEEF signature motif highlighted in
blue). The disordered parts of the interdomain linkers are shown in gray. Labels with a prime indicate symmetry-related elements. The two-fold sym-
metry axes are shown as thin, straight lines. (A andC) Nonactivated PleD (Chan et al., 2004) is associated to a loose dimer. The active sites (A sites) are
occupied by c-di-GMP, which crosslinks to an adjacent dimer (not shown). Intercalated (c-di-GMP)2 dimers are bound to allosteric inhibition sites I
and I0. Each inhibition site is comprised of a primary inhibition site on DGC (Ip; Arg359, Asp362, Arg390) and a secondary site on the adaptor domain
(Is,D2 ;R148, R178). (B and D) In the activated structure, the phosphorylation site (P site) is modified by BeF3
 and Mg2+, and the active site (A site)
harbors GTPaS/Mg2+. (C-di-GMP)2 dimers are bound to the dyad-related sites I and I
0. Each site is comprised of the primary Ip site, as in the non-
activated structure, and a secondary I site of the symmetry-related DGC (Is,DGC; R313; also see Figure 6). The two A sites face in opposite directions,
rendering the enzyme catalytically incompetent.Feedback Inhibition Probed by Mutagenesis
PleD shows noncompetitive product inhibition with a Ki of
about 0.5 mM (Chan et al., 2004) (Table 2). Crosslinking of
the DGC domain to the D2 domain, as seen in the crystal
structure of nonactivated PleD, has been proposed to be
the mechanism of product inhibition in PleD, since this
would prevent the productive encounter of the two GTP-
loaded enzyme domains (Chan et al., 2004). To test the
‘‘inhibition by domain immobilization’’ hypothesis, perti-
nent PleD mutants have been analyzed recently (ChristenStructure 15, 915et al., 2006). Mutations of primary I site (Ip) residues were,
apart fromR390A, largely deleterious for activity and, thus,
inconclusive. Mutation R390A, however, showed a con-
siderably increased Ki. Truncation of the secondary I site
residues on D2 (Is,D2; mutant R148A/R178A), on the other
hand, did not affect feedback inhibition.
Here, we applied a photometric pyrophosphate assay
to reinvestigate this Is,D2 mutant and to probe the role of
the secondary Is,DGC site (Arg313). As can be seen from
Table 2, mutating the Is,D2 or the Is,DGC site alone had a–927, August 2007 ª2007 Elsevier Ltd All rights reserved 919
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Structure of Activated PleDFigure 3. Structural Changes Invoked by BeF3
 Modification of Asp53
(A) Comparison of the Ca traces of the D1/D2 PleD stem in its activated (D1, red; D2, yellow) and nonactivated (gray) conformation after superposition
of the D1 domains. Residues of the acidic pocket as well as Thr83 and Phe102 are shown in full.
(B) Blow-up of the superimposed D1 domains around the activation site; residues involved in pseudo phosphorylation are shown in full. The omit map
for Asp53-BeF3
 and the associated Mg2+ ion is depicted at 3a.920 Structure 15, 915–927, August 2007 ª2007 Elsevier Ltd All rights reserved
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Structure of Activated PleDmoderate effect on the inhibition constants, with a 10-fold
and 2-fold increase, respectively. Our values deviate
slightly from those measured by Christen et al. (2006) for
wild-type and R148A/R178A PleD, possibly because their
data had been measured by a different technique (thin-
layer chromatography). Furthermore, the published Ki
values were actually IC50 values. Truncating both second-
ary I sites in the triple mutant R148A/R178A/R313A in-
creased the Ki by more than 60-fold. Interestingly, it was
not possible to inhibit this mutant completely, with the
inhibited state showing a residual kcat
0 rate constant of
about 5%of kcat (Table 2; Figure S2D, see the Supplemen-
Figure 4. Intermonomer D1/D20 Contact before and after
Activation
(A andB) In the dimeric stem, all shown contacts occur twice due to the
two-fold symmetry. Interface residues are shown in full. (A) In nonacti-
vated PleD, the interaction is restricted to a small contact patch around
Tyr26. In (B) activated PleD, there is a multitude of polar and ionic
interactions and an apolar contact between Leu124, Val125 (green
spheres,) and the corresponding residues of the symmetry-related
D10 (not shown). A putative sulfate ion is found on the symmetry axis
crosslinking Ag117 and Arg121 with their symmetry mates.Structure 15, 915tal Data available with this article online). All mutants, but
in particular those involving Is,D2 residues, showed consid-
erably elevated activity (Table 2). This may be due to a
decreased dimerization KD of the nonactivated mutant
proteins.
The KD of c-di-GMP binding to the triple mutant is about
4 mM (ITC measurement, data not shown) and, thus, is in-
creased by only a factor of about 10 with respect to PleD
wild-type (R.P. et al., unpublished data). This affinity most
probably is due to c-di-GMP binding to the uncompro-
mised Ip site. In summary, the data indicate that the two
immobilization modes operate redundantly, i.e., the integ-
rity of only one of the Is sites is required for noncompetitive
product inhibition, presumably via domain crosslinking.
DISCUSSION
DGCs play a central role in bacterial c-di-GMP signaling.
Therefore, their action, synthesis of the secondary mes-
senger, must be tightly controlled (Christen et al., 2006).
Comparison of the structures of nonactivated and acti-
vated PleD allows us to propose the mechanisms of acti-
vation by phosphorylation and, unexpectedly, suggests
two redundant modes of feedback inhibition. For a sche-
matic overview of the various structural states of PleD,
see Figure 7. Furthermore, the binding mode of the sub-
strate analog GTPaS gives insight into the catalytic mech-
anism of the cyclization reaction.
Activation
It has recently become apparent that BeF3-modified Rec
domains of RR transcription factors of the OmpR/PhoB
family form two-fold symmetric homodimers (Bachhawat
et al., 2005; Toro-Roman et al., 2005a, 2005b). Since their
DNA-binding domains bind cooperatively to their target
sequences, it was suggested that protein dimerization is
the mechanism of activation. In some cases, the active
dimer structure was also seen in crystals of the native pro-
tein (Toro-Roman et al., 2005a, 2005b), which may, how-
ever, be of no physiological relevance considering the
high protein concentration needed for crystallization.
In PleD, the signal generated by pseudo phosphoryla-
tion of Asp53 is transduced to the a4-b5-a5 face, where
it promotes the D1/D2 rearrangement, which, in turn, facil-
itates dimerization. As in other Rec domains, the con-
served Phe/Tyr at the center of this interface follows the
movement of a Thr/Ser and changes its rotameric state.
Themovement of Phe102 is compensated by a slight twist
of the C terminus of helix a4, allowing residues Ile92 and
Leu95 to make apolar interdomain contacts with Ala263.
Together with other rather subtle differences at the a4-
b5-a5 face of D1 a substantial domain rearrangement is
induced (Figure 3A). It is unlikely that these rearrange-
ments are caused by crystal packing, since, in the loosely(C and D) Close-up view of the D1/D2 interface in the (C) nonactivated and (D) activated state showing the quasi-two-fold symmetric interface. Both
domains contribute their a4-b5-a5 face. The viewing direction is along the quasi-dyad. All residues of the D1/D2 interface aswell as Thr83 and Phe102
are shown in stick and sphere representation for polar and apolar residues, respectively. Residues, which do not interact in one state, but do so in the
other, are shown in white.–927, August 2007 ª2007 Elsevier Ltd All rights reserved 921
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Structure of Activated PleDFigure 5. Substrate Analog GTPaS and Mg2+ Bound to the Active Site of PleD
The omit map for the ligands is contoured at 3s. The DGC domain is shown in ribbon representation; the GGEEF signature hairpin is shown in dark
blue, and all interacting residues and the P loop main chain (residues 328–331) are shown in full. (c-di-GMP)2 bound to the Ip site of the DGC domain
can be seen in the rear.packed crystals (VM = 3.8 A˚
3/Da), the crystal contact areas
are more than 2-fold smaller than the dimer interface.
Interestingly, the two PleDRec domains of a given chain
interact quasi-two-fold symmetrically and in a very similar
way as what is observed for the homodimerization of Rec
domains of the OmpR/PhoB subfamily. While the a4-b5-
a5 face is the interaction surface in both cases, the similar-
ity even extends to the residue level. In PleD, Asp101/
Arg115 and Asp250/Arg264 form two quasi-isologous
interdomain salt bridges at the center of the interface (Fig-
ures 3C and 3D), whereas homologous residues form
isologous interchain salt bridges in the Rec domains of the
OmpR/PhoB family (e.g., Asp99/Arg113 for ArcA) (Toro-
Roman et al., 2005a).
DGCs catalyze the condensation of two identical sub-
strates (GTP) to form the two-fold symmetric c-di-GMP
product. Since the DGC domain binds only one substrate,
two such domains are needed for catalysis, as depicted
in the mechanistic model of Figure 7 (state 4). Control of
dimerization allows for simple and efficient regulation of
the catalytic activity, as the reaction type for the encounter
of substrate-loaded DGC domains is changed from bi- to
unimolecular. At the high protein concentration of 20 mM
used in the enzymatic assays (Table 2), dimerization of
nonactivated PleD with a KD of about 100 mM is not negli-
gible, explaining the observed constitutive activity. The
physiological PleD concentration is not known and may
vary within the cell. But, clearly, activation by reduction of
the dissociation constant, KD, will bemost effective at pro-
tein concentrations well below the KD of nonactivated
PleD. Indeed, it has been shown that, at a lower protein
concentration of 5 mM, the catalytic rate is enhanced by
a factor of 35 upon BeF3
 modification, and that it is the
dimeric species that carries the activity (R.P. et al., unpub-
lished data).922 Structure 15, 915–927, August 2007 ª2007 Elsevier Ltd AllFor WspR from Pseudomonaas fluorescens, which is a
DGC with a single N-terminal Rec domain, a more indirect
dimerization mechanism, with phosphorylation relieving
the dimer interface obstruction caused by the effector do-
main, has been proposed (Malone et al., 2007). For RRp1
from Borrelia burgdorferi, which has the same Rec-DGC
domain organization, phosphorylation-dependent cyclase
activity has been demonstrated (Ryjenkov et al., 2005).
Thus, in these cases, a second Rec-like domain such as
the adaptor domain of PleD appears to be dispensible
for dimerization, and it may serve an additional regulatory
function in RRs with a Rec-Rec-DGC domain composition
(see below). How DGCs without Rec domains are acti-
vated remains to be investigated. Several of them may be
constitutive dimers such as DgcA (CC3285) from C. cres-
centus with its putative N-terminal coiled-coil domain
(P.W., unpublished data).
Catalysis
The active site of the DGC domain of PleD is identified by
the bound substrate analog GTPaS. It consists of well-
defined subsites for the b- and g-phosphates and for the
guanine base (Figure 5), which explains the observed sub-
strate specificity (Chan et al., 2004; Paul et al., 2004). The
structural similarity of the DGC domain to adenylate cy-
clase (AC) and DNA polymerase (POL) has been pointed
out (Chan et al., 2004). From this work, it is apparent
that the similarity also extends to the mode of substrate
binding as far as the position of the terminal phosphates
close to the P loop, the presence of metal B, and its coor-
dination by the phosphates and two invariant carboxylates
(D327 and E370 in PleD) are concerned. Metal site A is
also occupied in one of the subunits (Figure 5), but the
a-phosphate is not in coordinating distance as in the bac-
terial AC CyaC (Steegborn et al., 2005) and in POLrights reserved
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Structure of Activated PleDFigure 6. Crosslinking of the DGC Domains by c-di-GMP
(A) Ribbon diagram of the DGC dimer along its symmetry axis; both
(c-di-GMP)2 ligands and interacting residues are shown in full. The
(c-di-GMP)2 ligands are bound to the I site (IP site and the Is,DGC site
of the adjacent subunit).
(B) Close-up view of the intercalated (c-di-GMP)2 ligand, which cross-
links the two DGC domains (dark- and light-green surface representa-
tion) by binding to the Ip (Arg359, Asp362, Arg390) and the Is,DGC
(R3130) site of the adjacent domain.Structure 15, 91(Doublie et al., 1998). This may be caused by the thiol
modification of the ligand or the absence of the second
substrate. Modeling shows that moderate torsional ad-
justments can bring the a-phosphate in coordinating dis-
tance tometal A, with an orientation ready for in-line attack
onto the Pa-Pb diester bond. This can occur without
compromising binding of the terminal phosphates or the
guanine.
The role of the conserved Glu371 in DGCs (Figure S1)
has not been clarified, but it may coordinate metal A tran-
siently and/or serve as a proton acceptor for the incoming
30-hydroxyl of the other subunit. Indeed, mutagenesis has
shown that Glu371 is as indispensable for catalysis as are
the magnesium ligands Glu370 (Christen et al., 2006) and
Asp327 (data not shown). Another conserved residue in
the active site is Lys332, whose side chain amino group
can easily adopt a position from which it could stabilize
the charge of the pentavalent phosphoryl transition state
and the pyrophosphate leaving group (Figure S1). The
same role has been postulated for the nonhomologous
Arg1150 in CyaC (Steegborn et al., 2005).
To form the catalytically competent enzyme-substrate
complex (Michaelis-Menten complex), two substrate-
loaded DGC domains have to line-up in antiparallel orien-
tation, such that the 30-hydroxyl groups of the bound sub-
strates are brought in close proximity to the a-phosphate
of the other GTP molecule and such that they are properly
positioned to perform an intermolecular in-line nucleo-
philic attack onto Pa from the side opposing the suscepti-
ble Pa-Pb diester bond. Modeling shows that this can
be achieved without clashes in a dimeric arrangement, in
which helix a4 of one domain contacts the small b sheet
(b0, b00) of the symmetry-related domain (Figure S1). The
interface carries a number of ionic side chains that proba-
bly are involved in intermolecular salt bridges. The model
of the (DGC)2-c-di-GMP product complex obtained after
only minor rearrangements of the reactive groups (Fig-
ure S1B) is different from that observed experimentally
in nonactivated PleD (Chan et al., 2004), where c-di-GMP
crosslinks A sites of adjacent dimers. This is due to a differ-
ence in the position of the ribose and a-phosphate moie-
ties relative to the protein, whereas the guanine base is
bound in the same way. The orientation of the product
in the active site of nonactivated PleD is most probably
enforced by the artifactual, ligand-mediated dimer-dimer
association in the crystal.
The close resemblance of the constellation of reactive
groups and metal ions in the modeled PleD Michaelis-
Menten complexwith that in ACandPOL suggests that the
same two-metal-assisted mechanism for phosphodiester
formation as suggested for ACs (Tesmer et al., 1999) and
for POLs (Steitz, 1999) is operational in DGCs. More ki-
netic and mutagenesis experiments have to be performed
to reveal the precise catalytic mechanism of DGCs.
Feedback Inhibition
DGCs exhibit exquisite noncompetitive product inhibition,
as demonstrated biochemically for PleD (Chan et al.,
2004; Paul et al., 2004) and for DgcA from C. crescentus5–927, August 2007 ª2007 Elsevier Ltd All rights reserved 923
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Structure of Activated PleDTable 2. Kinetic Data of Nonactivated Wild-Type and Mutant PleD
Wild-type PleD PleD R148A/R178A PleD R313A PleD R148A/R178A/R313A
IC50 (mM) 7 ± 2 17 ± 4 9 ± 2 30 ± 5
Ki (mM) 0.5
a 5 0.9 33
Ks (mM) 26 20
a 21 25
kcat (mM c-di-GMP/[s $ mM PleD]) 9.0 $ 10
4 1.5 $ 102 4.0 $ 103 1.6 $ 102
kcat
0 (mM c-di-GMP/[s $ mM PleD]) 0a 0a 0a 8.1 $ 104
IC50 values represent experimental values with estimated standard deviations based on twomeasurements at GTP concentrations
of 100 mM and 500 mM. The concentration of the protein was 20 mM. The other kinetic parameters have been obtained by fitting
numerical simulations to the time course of c-di-GMP concentration at various inhibitory concentrations (Figure S2). In the simple
kinetic scheme, enzyme and substrate as well as enzyme and product are in thermodynamic equilibrium, with dissociation con-
stants of Ks and Ki, respectively, with the product binding noncompetitively to an allosteric site. Also, product and substrate binding
are assumed to be independent of each other. kcat and kcat
0 are the catalytic rate constants of substrate turnover for noninhibited
and inhibited protein, respectively. The fitted values for the on-rate constants of substrate and product ranged between 100 s1 and
350 s1. It should be noted that the fits for PleD wild-type andmutant R148A/R178A were poor (Figures S2A and S2B), and, hence,
the corresponding parameters not very well determined. This may be due to the simplicity of the kinetic model.
a Parameter was fixed in simulation.(Christen et al., 2006), and, based on conserved Ip sites,
this is expected to be the case for the majority of DGC do-
mains (Christen et al., 2006). Feedback inhibition prevents
futile GTP consumption and probably defines an upper924 Structure 15, 915–927, August 2007 ª2007 Elsevier Ltd Allceiling for the concentration of the second messenger c-
di-GMP in the bacterial cell. Christen et al. (2006) showed
that the allosteric Ip site is crucial for binding and product
inhibition and suggested that communication between theFigure 7. Mechanistic Model of PleD Regulation
The model is adapted from Chan et al. (2004). The DGC domain (green) is connected via a flexible linker to the stem (receiver domain D1 [red] and
adaptor domain D2 [yellow]) and is supposed to be mobile relative to it. (Upper row) Activation. Phosphorylation of domain D1 leads to a rearrange-
ment of the stem domains, which, in turn, allows for formation of a tight dimeric stem (3). The dimeric arrangement is a prerequisite for an efficient and
productive encounter of the two substrate-loaded DGC domains to form the c-di-GMP product (4). (Lower row) Product inhibition. Dimeric product
molecules, (c-di-GMP)2, can crosslink the primary inhibition site onDGC, Ip, with a secondary binding site either on D2, Is,D2 (5) or on the adjacent DGC
domain, Is,DGC (6). The former structure has been observed experimentally with nonactivated PleD (Chan et al., 2004), the latter structure is presented
in this report. In both cases, the DGC domains become immobilized, and the active sites are hampered from a productive encounter. Note that a
possible direct communication between Ip and A sites (Christen et al., 2006) is not depicted.rights reserved
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Structure of Activated PleDIp site and the active site of a DGC domain could cause the
observed noncompetitive product inhibition. However, in
the nonactivated structure (Chan et al., 2004), the enzy-
matic product in the form of two intercalated c-di-GMP
molecules was found to crosslink the Ip with the Is,D2 site
on the adjacent D2 domain (Figure 7, state 5). Therefore,
an ‘‘inhibition by domain immobilization’’ mechanism, in
which domain crosslinking by c-di-GMP would prevent
productive encounter of the two enzymatic domains of
the dimer, was proposed. Indeed, (c-di-GMP)2 can be re-
garded as a multivalent ligand that offers, among other
features, theO6-N7 edges of its four guanyl bases for spe-
cific pairing with arginine guanidyl groups, as observed in
DNA-protein interactions. In nonactivated PleD, the ligand
crosslinks the well-defined and well-conserved (Christen
et al., 2006) Ip site on the a2-b2 corner of DGC (formed
by Arg359, Asp362, Arg392) with arginines 148 and 178
of D2 (Is,D2).
In the present structure, a similar mechanism can be
deduced. In this mechanism, the dimeric ligand is again
bound to the Ip site, but its other valency crosslinks to a
hitherto unrecognized, to our knowledge, secondary site
on the adjacent DGC domain of the dimer (Is,DGC). As a re-
sult, the DGC domains interact in a nonproductive manner
with the two A sites, which point away from each other
(Figure 2B). Our functional analysis of pertinent mutants
(Table 2) suggests that domain immobilization might in-
deed contribute to feedback regulation, and that the two
inhibition modes operate redundantly (Figure 7, states 5
and 6). The advantage of redundancy in this context is
not clear, but we note that efficient DGC-DGC crosslinking
obviously can operate only after dimerization, while D2-
DGC crosslinking occurs within the nonactivated mono-
mer. Why the triple mutant is not fully active upon c-di-
GMP binding, but rather switches to a slower rate (Table
2), remains to be investigated. This may be due to the
residual binding capacity of the mutated Is sites, the exis-
tence of additional Is sites with low affinity, or a change of
active site structure and/or dynamics upon allosteric
product binding to the Ip site, as suggested by molecular
simulations (Christen et al., 2006).
The relevance of feedback inhibition has been dis-
cussed before upon recognizing that the R359xxD362 motif
of the Ip site is largely conserved (Christen et al., 2006). It is
present in 59% of all GGDEF domain sequences of the
current PFAM release (5200 sequences) that have an in-
tact GGD(E)EF motif and are, therefore, putative DGCs.
A large part of these seem to operate via c-di-GMP cross-
linking of Ip with an Is,DGC site, as observed in the present
PleD structure. This can be inferred from the fact that 64%
of the DGC sequences with the RxxD motif show an argi-
nine at position 313 of helix a0 or at a position one turn of
the helix farther up (positions 316 and 317), fromwhere the
long side chain probably could also reach the ligand. Co-
variation calculations show a significant correlation of 0.45
(0.32, 0.61) for simultaneously finding the RxxD motif and
an arginine at position 313 (316, 317). Of the subset of
19 DGCs for which guanylate cyclase activity has been
shown experimentally (see Figure S4 in Christen et al.Structure 15, 915[2006]), 14 display the RxxD motif of the Ip site, and all
but one display an arginine residue at one of the second-
ary positions.
This implies that catalytic domain immobilization by
DGC-DGC crosslinking is a rather common feedback inhi-
bition mechanism of DGCs and does not rely on second-
ary inhibition sites on other domains. This autonomy of the
DGCdomain has probably been an advantage in evolution
to conserve feedback inhibition. Interestingly, feedback
inhibition is also observed in the prototype of a ‘‘single-
domain’’ DGC, DgcA from C. crescentus, whose se-
quence exhibits both Ip and Is,DGC sites as well as a small
N-terminal extension of possibly coiled-coil structure for
dimerization (Christen et al., 2006).
The multivalency of the second messenger c-di-GMP
appears perfectly suited for signal transfer. Here, we
showed evidence that it can be utilized for domain cross-
linking, which elicits large structural changes and which
may well also work for downstream signaling processes.
Interestingly, c-di-GMP binds to the N terminus of the
PilZ effector domain (Christen et al., 2007), i.e., to a strate-
gic position where it could control domain arrangement in
multidomain targets carrying this domain. The identifica-
tion of additional c-di-GMP effector proteins will reveal
to what extent this notion can be generalized.
EXPERIMENTAL PROCEDURES
Mutagenesis, Expression, and Purification
PleD mutations, D327A, R313A and R148A/R178A/R313A, were per-
formed by using the QuickChange II Site-Directed Mutagenesis Kit
(Stratagene) based on pRUN plasmids (derived from the pBR322
vector) containing the C-terminally His6-tagged wild-type gene (Chan
et al., 2004) or the R148A/R178A double mutant (Christen et al.,
2006). C-terminally His6-tagged full-length PleD and mutants were ex-
pressed in the E. coli BL21(DE3)pLysS strain, induced by 0.5 mM IPTG
(3–4 hr, 30C). Cells were washed twice with 20 mM Tris-HCl (pH 8.0),
500 mM NaCl buffer and were stored at 80C. The proteins were
purified by affinity chromatography with 5 ml HisTrap columns (GE
Healthcare) and 200 mM imidazole for elution. The pooled protein
fractions were concentrated and further purified by size-exclusion
(SEC) chromatography by using the Superdex 200 HR 26/60 column
(GE Healthcare) and 20 mM Tris-HCL (pH 8.0), 100 mM NaCl as run-
ning buffer (SEC buffer). For this step, the protein concentration was
kept low (5–10 mg/ml) to ensure dissociation and removal of bound
c-diGMP. The protein was concentrated to 10 mg/ml, aliquoted, and
stored at 20C for further use.
Activation of PleD by BeF3
- Modification
Activation of PleDwas accomplished by supplementing the SEC buffer
with BeCl2, NaF, and either MgCl2 or MnCl2 (A buffer). Final concentra-
tions were 200 mM for PleD, 1 mM for BeCl2, 10 mM for NaF, 10mM for
MgCl2, and 1 mM for MnCl2. The protein was incubated for at least
30 min before experiments were conducted.
C-di-GMP
Pure samples of c-di-GMP were obtained from N. Amiot, Department
of Chemistry, University of Basel. It was chemically synthesized
according to procedures by Amiot et al. (2006).
Enzymatic Assays
DGC activity of wild-type andmutant PleDwas analyzed bymonitoring
the production of pyrophosphate by using a pyrophosphatase-cou-
pled spectrophotometric assay. Details are given elsewhere (Chan–927, August 2007 ª2007 Elsevier Ltd All rights reserved 925
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Structure of Activated PleDet al., 2004). The kinetic data were fitted to numerical simulations of
a scheme of noncompetitive product inhibition by using the program
Berkeley Madonna.
Analytical Size-Exclusion Chromatography
Dimerization of PleD was monitored by size-exclusion chromatogra-
phy (SEC) by using a Superdex 200 HR 10/30 column (GE Healthcare).
SEC and A buffers were used as running buffers for nonactivated and
activated protein samples, respectively. Runs were performed on an
A¨KTApurifier (GE Healthcare) system at a flow rate of 0.7 ml/min.
The concentrations of the eluted peak fractions were measured by
an online refractometer (Optilab rEX, Wyatt Technology).
Isothermal Titration Calorimetry
Samples of the PleD mutant protein R313A were first diluted 15-fold
either in SEC or A buffer (containing Mn2+ as divalent cation) and
then concentrated by using a 15 ml Amicon Ultra MWCO 10 kDa (Milli-
pore) concentrator. Protein samples and buffers were degassed (Ther-
moVac,MicroCal) at 2 below the temperature used in the experiments
before loading into the VP-isothermal titration calorimetry (ITC) (Micro-
cal, Northampton, MA). Details of the ITCmeasurement procedure and
analysis of self-association have been described previously (McPhail
and Cooper, 1997; Velazquez-Campoy et al., 2004). In short, 10 ml
samples of nonactivated (two experiments at concentrations 929 mM
and 861 mM) and activated (108 mM and 99 mM) PleD were injected
into the cell filled with buffer (1.4 ml volume) at 6 min intervals. The
measurements of nonactivated and activated protein were performed
at 15C and at 10C, respectively. Both measurements of each state
were fit together to obtain global DH and KD values. A constant back-
ground heat, produced by the dilution of the titrant, residual differ-
ences in the buffer composition in syringe and cell, and technical ef-
fects was eliminated by allowing for a constant heat contribution
(Qdil) as another fit parameter upon data evaluation.
Crystallography
Crystallization of activated PleD was performed at room temperature
by the hanging-drop vapor-diffusion technique. Before crystallization,
c-di-GMP and Rp-GTP-a-S (BioLog) were added with final concentra-
tions of 0.2 mM and 1mM, respectively, to BeF3
/Mg2+-modified PleD
samples (final concentration 100 mM). A (1 ml + 1 ml) mixture of protein
and well solution (0.1 M HEPES [pH 8.0], 0.73 M Na2SO4) gave rise to
crystals of needle shape. Diffraction data were collected from a single
crystal at the Swiss Light Source, Paul-Scherrer-Institute, Villigen,
Switzerland, and were processed with MOSFLM/SCALA (CCP4,
1994). Orientations and positions of individual domains were deter-
mined by molecular replacement with the structure of nonactivated
PleD (PDB code 1W25) by using PHASER (McCoy, 2007). The model
was built by using COOT (Emsley and Cowtan, 2004) and was refined
with REFMAC (CCP4, 1994). Two-fold NCS restraints were imposed.
Supplemental Data
Supplemental data include a figure of the modeled structure of the
competent PleD-substrate complex, a figure of the PleD-product
complex and a figure with the kinetic data of wild-type and mutant
PleD and are available at http://www.structure.org/cgi/content/full/
15/8/915/DC1/.
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